BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PDX1
,
calcium channel activity
,
Obesity
,
Kidney
,
Avian flu virus
,
Bleomycin
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vaccinia
(phenotype)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
CCL2
THBS1
CD14
VCAN
SIRPA
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
innate immune response
defense response to other organism
vesicle
defense response to virus
regulation of immune response
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cowpox, monkeypox or vaccinia virus infected HeLa cells expression patterns
PBMCs post vaccination with modified vaccinia virus Ankara expressing antigen 85
PANC-1 pancreatic carcinoma cells infected with oncolytic vaccinia virus GLV-1h153
Immune cells and spleens from mice infected with different viral vector platforms
Follicular helper T-cells with GC specific TCF1 LEF1 double knockout post vaccinia virus infection
Explore Curated Studies Results
Literature
Most Relevant Literature
Immune control strategies for vaccinia virus-related laboratory-acquired infections.
Evaluating anti-Orthopoxvirus antibodies in individuals from Brazilian rural areas prior to the bovi…
Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutane…
Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.
Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation and Treatment of Eye Complications of Vaccinia Vaccination
Safety Study of Modified Vaccinia Virus to Cancer
Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
High Dose IMVAMUNE® in Vaccinia-Naive Individuals
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ